Fred Alger Management, LLC Becton Dickinson & CO Transaction History

Fred Alger Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$254.9 - $283.59 $2.4 Million - $2.67 Million	9,428 New	9,428 $2.44 Million
Q3 2020 Nov 13, 2020	SELL	$215.77 - $276.76 $14,240 - $18,266	-66 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$195.69 - $279.01 $12,915 - $18,414	66 New	66 $15,000
Q2 2019 Aug 14, 2019	SELL	$217.4 - $246.08 $11,304 - $12,796	-52 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$204.73 - $257.93 $4,504 - $5,674	22 Added 73.33%	52 $12,000
Q3 2018 Nov 14, 2018	SELL	$233.07 - $256.0 $4,894 - $5,376	-21 Reduced 41.18%	30 $8,000
Q4 2017 Feb 14, 2018	SELL	$189.0 - $222.64 $5,103 - $6,011	-27 Reduced 34.62%	51 $11,000
Q3 2017 Nov 14, 2017	BUY	$186.89 - $198.9 $14,577 - $15,514	78	78 $15,000

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.3B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.